Inhibition of IgE-Induced Upregulation of FcRIα by Antibody CGP51901 in Cultured Basophils
Experiment No. . | Day 0 . | Day 7 . | |||
---|---|---|---|---|---|
Control . | 51901 . | IgE* . | IgE + CGP51901 . | ||
1 | 89† | 86 | 89 | 132 | 89 |
2 | 56 | 48 | 37 | 80 | 45 |
3 | 98 | 64 | 57 | 103 | 64 |
Average fold upregulation | (1.00) | 0.82 ± .09 | 0.75 ± .13 | 1.32 ± .14 | 0.83 ± .10 |
Experiment No. . | Day 0 . | Day 7 . | |||
---|---|---|---|---|---|
Control . | 51901 . | IgE* . | IgE + CGP51901 . | ||
1 | 89† | 86 | 89 | 132 | 89 |
2 | 56 | 48 | 37 | 80 | 45 |
3 | 98 | 64 | 57 | 103 | 64 |
Average fold upregulation | (1.00) | 0.82 ± .09 | 0.75 ± .13 | 1.32 ± .14 | 0.83 ± .10 |
CGP51901 = chimeric monoclonal anti-IgE antibody at 10 μg/mL.
IgE = PS myeloma at 500 ng/mL.
Listed values are net fluorescence units for monoclonal antibody 22E7 binding as determined by flow cytometry; average data are calculated as fold upregulation using day 0 values as the reference point for each experiment.